• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    Rexahn Pharmaceuticals, Inc. (RNN)

    -NYSE MKT
    0.26 Down 0.01(2.29%) Jun 24, 4:02PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development3,469  2,916  3,104  3,235  
    Selling General and Administrative1,395  1,451  1,555  1,585  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,864) (4,367) (4,659) (4,820)
    Income from Continuing Operations
    Total Other Income/Expenses Net885  1,726  632  1,586  
    Earnings Before Interest And Taxes(3,979)(2,641)(4,027)(3,234)
    Interest Expense170  211   -   -  
    Income Before Tax(4,149)(2,852)(4,027)(3,234)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(4,149)(2,852)(4,027)(3,234)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (4,149) (2,852) (4,027) (3,234)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (4,149) (2,852) (4,027) (3,234)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.